Compile Data Set for Download or QSAR
Report error Found 17 Enz. Inhib. hit(s) with all data for entry = 8881
TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426312(US10513534, Compound 401)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426315(US10513534, Compound 403)
Affinity DataIC50: 250nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426319(US10513534, Compound 407)
Affinity DataIC50: 250nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426317(US10513534, Compound 405)
Affinity DataIC50: 250nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426318(US10513534, Compound 406)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426314(US10513534, Compound 402)
Affinity DataIC50: 5.50E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426323(US10513534, Compound 411)
Affinity DataIC50: 6.25E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426322(US10513534, Compound 410)
Affinity DataIC50: 6.25E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426321(US10513534, Compound 409)
Affinity DataIC50: 6.25E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426320(US10513534, Compound 408)
Affinity DataIC50: 6.25E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426319(US10513534, Compound 407)
Affinity DataIC50: 6.25E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426318(US10513534, Compound 406)
Affinity DataIC50: 6.25E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426317(US10513534, Compound 405)
Affinity DataIC50: 6.25E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426315(US10513534, Compound 403)
Affinity DataIC50: 6.25E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426312(US10513534, Compound 401)
Affinity DataIC50: 6.25E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426316(US10513534, Compound 404)
Affinity DataIC50: 1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM426316(US10513534, Compound 404)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
Go to US Patent